Major cable and broadcast news outlets seem to have largely ignored a Wall Street Journal report that Donald Trump Jr. stands to potentially benefit financially from a deal between BlinkRx and the government-run TrumpRx pharmaceutical program. Apparently, neither The New York Times or The Washington Post covered the Journal’s findings either.
    • foodandart@lemmy.zip
      20·
      14 days ago

      Two words explain why: Brendan Carr.

      Any broadcast that upsets Trump’s grift, is going to get a lot of heat from FCC Chairman and Trump stooge, Brendan Carr.

  • pelespirit@sh.itjust.works
    32·
    14 days ago

    On September 30, President Donald Trump announced TrumpRx, a government-run platform scheduled to launch in 2026 that would funnel consumers to drug companies’ direct-sale websites — precisely the service BlinkRx announced it could help facilitate in August. Donald Trump Jr. joined the company’s board in February of this year, and also serves as a partner of the investment firm 1789 Capital, a “lead investor” in BlinkRx. According to the Wall Street Journal report, before the President’s TrumpRx reveal, a BlinkRx representative “told one drug company that BlinkRx could be involved with running the site on behalf of the Centers for Medicare and Medicaid Services.”

    • TeamAssimilation@infosec.pub
      14·
      14 days ago

      Which is just populist name calling, the real name is “Affordable Care Act”; but I guess riling people against affordable care was harder.

    • Joeffect@lemmy.world
      6·
      14 days ago

      Everything he wants it on Everything, not understanding the moment hes dead at the very least it all goes back… I guess he won’t care at that point…

  • Kirp123@lemmy.world
    10·
    14 days ago

    Junior has hoovered so much coke I’m surprised his nose hasn’t fell off his face by now.